Back to search

Finland· FI-REL-REL58826

Natriumklorid Abboxia

A sodium chloride product containing sodium chloride, registered in Finland by Abboxia AB. The same ATC class is registered in 7 of our 19 countries.

ATC A12CA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNatriumklorid AbboxiaATCA12CA01REGISTER NO.FI-REL-REL58826PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Sodium chloride is registered in 7 of 19 countries.

Countries holding a registration under ATC A12CA01 (sodium chloride), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Sodium chloride · ATC A12CA01

7 / 19 countries

  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Sodium chloride
Manufacturer
Abboxia AB
Country
Finland (FI)
ATC code
A12CA01
ATC class
Sodium chloride
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    105389
    100
    EUR 26.85

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for sodium chloride.

Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sodium chloride · interactions on record

3 records

  • 3 moderate

Most severe, free to view

  • TolvaptanC03XA01moderate
  • TolvaptanG04BX21moderate
  • LithiumN05AN01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/93f2fe36-0338-49ee-9e60-ca005076af14
GET /v1/drugs/93f2fe36-0338-49ee-9e60-ca005076af14?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "500 mg",
  "atc_label": "natriumkloridi",
  "ma_number": "39765",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL58826",
  "authorised_at": "2022-12-01"
}

See everything about sodium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.